Mechanism

Angiotensin II receptor / HMG-CoA reductase / NPC1L1

Assets acting on this target.

Class
ARB + statin + ezetimibe triple fixed-dose combination
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets